ABCL
Price
$2.22
Change
+$0.13 (+6.22%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
661.53M
40 days until earnings call
ATOS
Price
$0.69
Change
+$0.04 (+6.15%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
88.82M
46 days until earnings call
Ad is loading...

ABCL vs ATOS

Header iconABCL vs ATOS Comparison
Open Charts ABCL vs ATOSBanner chart's image
AbCellera Biologics
Price$2.22
Change+$0.13 (+6.22%)
Volume$40.68K
Capitalization661.53M
Atossa Therapeutics
Price$0.69
Change+$0.04 (+6.15%)
Volume$3.27K
Capitalization88.82M
ABCL vs ATOS Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. ATOS commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a StrongBuy and ATOS is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (ABCL: $2.22 vs. ATOS: $0.69)
Brand notoriety: ABCL and ATOS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 100% vs. ATOS: 90%
Market capitalization -- ABCL: $661.53M vs. ATOS: $88.82M
ABCL [@Biotechnology] is valued at $661.53M. ATOS’s [@Biotechnology] market capitalization is $88.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileATOS’s FA Score has 1 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • ATOS’s FA Score: 1 green, 4 red.
According to our system of comparison, ATOS is a better buy in the long-term than ABCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 4 TA indicator(s) are bullish while ATOS’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 4 bullish, 5 bearish.
  • ATOS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ATOS is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а -8.26% price change this week, while ATOS (@Biotechnology) price change was -1.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.26%. For the same industry, the average monthly price growth was -7.43%, and the average quarterly price growth was -11.99%.

Reported Earning Dates

ABCL is expected to report earnings on May 13, 2025.

ATOS is expected to report earnings on May 19, 2025.

Industries' Descriptions

@Biotechnology (-5.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($662M) has a higher market cap than ATOS($88.8M). ABCL YTD gains are higher at: -28.669 vs. ATOS (-31.045). ATOS has higher annual earnings (EBITDA): -29.46M vs. ABCL (-204.15M). ABCL has more cash in the bank: 626M vs. ATOS (74.8M). ATOS has less debt than ABCL: ATOS (0) vs ABCL (65.4M). ABCL has higher revenues than ATOS: ABCL (28.8M) vs ATOS (0).
ABCLATOSABCL / ATOS
Capitalization662M88.8M745%
EBITDA-204.15M-29.46M693%
Gain YTD-28.669-31.04592%
P/E RatioN/AN/A-
Revenue28.8M0-
Total Cash626M74.8M837%
Total Debt65.4M0-
FUNDAMENTALS RATINGS
ATOS: Fundamental Ratings
ATOS
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLATOS
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 10 days ago
77%
Bullish Trend 17 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KKOYY10.260.09
+0.91%
Kesko OY
PRNDY19.940.14
+0.71%
Pernod Ricard S.A.
GPOX0.04N/A
N/A
GPO PLUS INC.
KYOCY11.27-0.05
-0.44%
Kyocera Corp.
LICYF0.33-0.03
-8.64%
Li-Cycle Holdings Corp.

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-6.28%
CRSP - ABCL
57%
Loosely correlated
-2.62%
NTLA - ABCL
56%
Loosely correlated
-6.40%
VCYT - ABCL
56%
Loosely correlated
-0.30%
BEAM - ABCL
55%
Loosely correlated
-9.70%
ABSI - ABCL
53%
Loosely correlated
-4.38%
More

ATOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATOS has been loosely correlated with ABOS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ATOS jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATOS
1D Price
Change %
ATOS100%
-3.25%
ABOS - ATOS
48%
Loosely correlated
-2.27%
ABCL - ATOS
43%
Loosely correlated
-6.28%
AXON - ATOS
42%
Loosely correlated
+2.90%
GBIO - ATOS
41%
Loosely correlated
-9.11%
NTLA - ATOS
41%
Loosely correlated
-6.40%
More